ORLEX HC Drug Patent Profile
Which patents cover Orlex Hc, and when can generic versions of Orlex Hc launch?
Orlex Hc is a drug marketed by Warner Chilcott and is included in one NDA.
The generic ingredient in ORLEX HC is acetic acid, glacial; hydrocortisone. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the acetic acid, glacial; hydrocortisone profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ORLEX HC?
- What are the global sales for ORLEX HC?
- What is Average Wholesale Price for ORLEX HC?
Summary for ORLEX HC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 3 |
| Patent Applications: | 5,313 |
| DailyMed Link: | ORLEX HC at DailyMed |
US Patents and Regulatory Information for ORLEX HC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Warner Chilcott | ORLEX HC | acetic acid, glacial; hydrocortisone | SOLUTION/DROPS;OTIC | 086844-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
